SURGERY PARTNERS INCSGRY
ASignal's systematic analysis rates SGRY as Neutral.
Reflects the latest available analysis · analyzed Oct 27, 2026
The case on SGRY
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong price momentum with MACD above signal line and expanding histogram
- Price trading significantly above 20-day and 50-day moving averages
- Bullish Bollinger Band positioning suggests strong upward momentum
- Extremely overbought RSI at 95.05, indicating high risk of correction
- Negative profit margin (-2.63%) and low return on equity (2.32%)
- High forward P/E of 139.46x with no earnings growth data
- Elevated debt-to-equity ratio of 1.17x
- No Reddit mentions, suggesting lack of retail investor interest
See the full verdict on SGRY
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes SGRY
Most investors never get a second opinion, let alone several. ASignal runs SGRY past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.